Trial Profile
The Effect of Androgen Deprivation Therapy With Enzalutamide on Bladder Cancer Chemoprevention
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 11 Jan 2018 Status changed from recruiting to discontinued due to low enrollment the sponsor withdrew support for study
- 19 Nov 2015 New trial record